PAHC - CIK 0001069899
The table below shows PHIBRO ANIMAL HEALTH CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $80.12M | $87.59M | $13.31M | $31.65M | $48.31M | $59.35M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$288.69M | -$48.19M | -$74.02M | -$22.58M | -$18.58M | -$120.39M |
| Dividends paid | $19.45M | $19.44M | $19.44M | $19.44M | $19.43M | $19.42M |
PHIBRO ANIMAL HEALTH CORP reported operating cash flow of $80.12M for fiscal year 2025. That is down 8.5% from $87.59M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $37.22M (FY 2016) to $80.12M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $207.13M | -$6.77M | $26.99M | $16.34M | -$17.00M | $40.94M |